【研究报告】体外膜肺氧合（ECMO）系统市场规模预计将从2022年的5.5068亿美元增长到2030年的8.0003亿美元；预计在预测期内增长率为 4.8%。
市场洞察和分析师观点：
体外膜氧合（ECMO）系统是生命支持机器，用于为严重呼吸或心力衰竭患者提供临时援助。 ECMO 系统的工作原理是从患者体内抽取血液，在体外为其充氧，然后将其返回患者体内。当其他治疗方法失败时，这些系统被用作最后的手段。他们通常受雇于重症监护室，需要专门的培训和专业知识才能操作。 ECMO 系统不能治愈肺或心脏损伤；它只是减轻肺部和心脏的负担，从而为器官在治疗期间恢复提供时间。呼吸系统和心血管疾病的患病率不断上升，以及老年人群心血管手术的增加，预计将推动 ECMO 系统市场的发展。此外，新生儿和儿科患者对 ECMO 系统的使用增加预计将为 ECMO 系统市场增长创造充足的机会。
增长动力和挑战：
心肺疾病主要影响人们的肺和心脏。这些疾病被归类为慢性阻塞性肺病（COPD）和心血管疾病。心血管疾病包括血管疾病、心律失常问题、冠状动脉疾病以及影响血管和心脏的心脏缺陷。此外，慢性阻塞性肺病由慢性支气管炎和肺气肿组成。
根据美国肺脏协会的数据，慢性阻塞性肺病是美国最主要的死亡原因，到 2022 年将影响约 1200 万美国人。据世界卫生组织称，到2021年，慢性阻塞性肺病将成为全球第三大死亡原因。慢性阻塞性肺病的高死亡率与急性加重有关，急性加重会导致呼吸肌衰竭，导致丧失独立呼吸的能力，从而导致死亡全身感染和哮喘。此外，根据 2021 年阻塞性肺病负担 (BOLD) 报告，预计未来 40 年全球慢性阻塞性肺病死亡率将上升，到 2060 年每年死亡人数将达到 540 万人。因此，随着慢性阻塞性肺病发病率的上升，对慢性阻塞性肺病的需求也随之增加。 ECMO 系统也在不断增加。
根据全球健康数据交换登记处的数据，2023 年全球充血性心力衰竭的患病率为 6434 万例。 CVD 包括种族、家族史和年龄；其他危险因素包括高血压、肥胖、吸烟、高胆固醇、缺乏运动和糖尿病。世界卫生组织估计，每年有 1790 万人因心血管疾病而丧生。制氧机可以成为医生降低死亡率的关键辅助手段。如果发生心力衰竭，由于心脏无法维持适当的氧气水平，因此需要借助外部设备来维持血氧水平。氧合器设备用于治疗心力衰竭患者。
因此，心肺疾病（心血管疾病和 COPD）患病率的上升增加了对 ECMO 系统的需求。
然而，与使用 ECMO 系统相关的各种风险因素可能会影响患者的病情。由于使用抗凝剂，出血是大多数使用 ECMO 系统的患者所经历的危险因素之一。此外，在某些情况下还观察到中风、感染、肾衰竭、机械故障等风险增加，这可能会阻碍 ECMO 系统市场的增长。
战略见解
报告细分和范围：
“全球 ECMO 系统市场规模”根据模式、应用、患者类型、最终用户和地理位置进行细分。根据模式，ECMO 系统市场分为静脉-动脉 (VA)、静脉-静脉 (VV) 等。根据应用，ECMO 系统市场分为呼吸系统和心脏病学。根据患者类型，ECMO 系统市场分为成人、儿科和新生儿。根据最终用户，ECMO 系统市场分为医院和诊所、心脏中心等。 ECMO系统市场按地域划分为北美（美国、加拿大和墨西哥）、欧洲（德国、法国、意大利、英国、俄罗斯和欧洲其他地区）、亚太地区（澳大利亚、中国、日本、印度、韩国、亚太地区其他地区）、中东和美国非洲（南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区）以及南美和非洲中美洲（巴西、阿根廷以及南美洲和中美洲其他地区）。
细分分析：
根据模式，ECMO 系统市场规模分为静脉-动脉 (VA)、静脉-静脉 (VA) VV）等。到 2022 年，静脉-动脉部分将占据最大的市场份额，并且由于气体交换的有效性和可靠性的提高以及心脏骤停患者的广泛使用（因为它有助于算法），预计未来几年将以最快的速度增长重建血流的生命支持技术。
ECMO 系统市场，按 Modality 划分 – 2022年和2030年
根据应用情况，ECMO系统市场分为呼吸科和心脏病科。到 2022 年，呼吸系统领域将占据最大的市场份额，并且由于呼吸系统疾病以及吸烟和吸烟（可能导致呼吸衰竭）的患病率不断增加，预计未来几年将以最快的速度增长。
根据患者类型，ECMO 系统市场分为成人、儿科和新生儿。 2022 年，按患者类型划分，成人细分市场占据最大市场份额。然而，由于新生儿群体中肺炎、呼吸窘迫综合征等呼吸系统疾病的患病率不断增加，预计未来几年新生儿市场的增长率最高。
根据最终用户，ECMO 系统市场分为医院和诊所、心脏中心等。到 2022 年，医院和诊所部门占据主要市场份额，并且由于呼吸系统疾病住院人数不断增加，以在规定的时间内接受治疗和护理，预计未来几年将出现显着增长。
区域分析：
ECMO 系统市场涵盖五个关键区域：北美、欧洲、亚太地区、南美和北美中美洲、中东和非洲非洲。 2022年，北美占据最大的ECMO系统市场份额，紧随其后的是欧洲，预计亚太地区在预测期内的复合年增长率最高。北美市场的主要增长因素是该地区心血管和呼吸系统疾病患病率的上升。它增加了慢性阻塞性肺病、慢性支气管炎、充血性心力衰竭等心肺疾病的发病率。根据美国肺脏协会的数据，2021 年美国约有 1250 万人被诊断患有慢性支气管炎、慢性阻塞性肺病和肺气肿。
此外，慢性支气管炎、慢性阻塞性肺病和肺气肿的发病率和患病率不断上升。这些疾病增加了大批患者的外科手术次数，从而推动了 ECMO 系统市场的增长。例如，在寿命健康系统研究中，美国每年进行约 50 万例心脏直视手术。此外，呼吸衰竭和传染病患病率的上升预计将进一步创造对 ECMO 系统的需求。
此外，心血管疾病患病率的上升是全球死亡的主要原因。在全球范围内，ECMO系统可以为紧急情况下的救生提供巨大帮助。根据世界卫生组织的数据，每年约有 1790 万人因心血管疾病而丧生，有利的报销政策也可能为 ECMO 系统的发展创造充足的机会。因此，心肺疾病的患病率和患病率的增加预计将导致预测期内 ECMO 系统市场的增长。
然而，亚太地区被认为是增长最快的地区-全球ECMO系统市场中不断增长的地区。中国、日本和印度等国家的该地区市场预计将大幅增长。市场的增长归因于市场参与者对发展中经济体的日益关注以及政府的支持性政策。尽管全球范围内存在有效且安全的预防策略，但心血管疾病（CVD）仍然是全球死亡和过早死亡的主要原因。该市场的增长主要归因于中国心房颤动（AF）患病率的增加、各种其他心脏病负担的增加以及该地区老年人口的增加预计将支持市场增长。根据世界心脏联合会的预测，2010年至2030年间，中国人口中缺血性心脏病和中风等心血管事件预计将增加50%。印度心脏协会表示，50%的心脏病发作发生在20岁以下50 岁以下，而 25% 的心脏病发作发生在 25 岁以下。该国男性和女性患心脏病的风险相同。
此外，中风是心房颤动常见且具有破坏性的并发症之一。大约三分之一的心房颤动患者没有症状，并且在出现症状之前，患者的心房颤动可能未被发现。当氧合器在心脏手术期间通过去除二氧化碳向动脉提供氧气时，心脏就不再需要执行泵血任务。因此，该地区心血管疾病的患病率不断上升，刺激了对 ECMO 系统市场的需求。
根据 Frontier Media 2022 年 6 月发布的公共卫生报告，最最近的中国慢性阻塞性肺病全国调查显示，中国的慢性阻塞性肺病病例几乎占全球所有慢性阻塞性肺病病
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Getinge Group
2. Medtronic plc
3. LivaNova PLC
4. XENIOS AG
5. Terumo Corporation
6. MicroPort Scientific Corporation
7. NIPRO Corporation
8. OriGen Biomedical, Inc.
9. ALung Technologies, Inc.
10. EUROSETS S.r.l
11. MAQUET Holding B.V. & Co. KG
12. Sorin Group
13. Medos Medizintechnik AG
14. Abbott Laboratories
15. Braile Biomedical
16. Edwards Lifesciences Corp
17. Elsius Biomedical Inc.
18. Spectrum Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For